These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 15357987)

  • 21. Synthesis and antimicrobial evaluation of 1-(benzofuran-2-yl)-4-nitro-3-arylbutan-1-ones and 3-(benzofuran-2-yl)-4,5-dihydro-5-aryl-1-[4-(aryl)-1,3-thiazol-2-yl]-1H-pyrazoles.
    Abdel-Wahab BF; Abdel-Aziz HA; Ahmed EM
    Eur J Med Chem; 2009 Jun; 44(6):2632-5. PubMed ID: 18995932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis, anticonvulsant and toxicity evaluation of 2-(1H-indol-3-yl)acetyl-N-(substituted phenyl)hydrazine carbothioamides and their related heterocyclic derivatives.
    Siddiqui N; Alam MS; Ahsan W
    Acta Pharm; 2008 Dec; 58(4):445-54. PubMed ID: 19103578
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of dynamin mediated endocytosis by the dynoles--synthesis and functional activity of a family of indoles.
    Hill TA; Gordon CP; McGeachie AB; Venn-Brown B; Odell LR; Chau N; Quan A; Mariana A; Sakoff JA; Chircop M; Robinson PJ; McCluskey A
    J Med Chem; 2009 Jun; 52(12):3762-73. PubMed ID: 19459681
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and in-vitro antibacterial activity of some novel N-nicotinoyl-1-ethyl-6-fluoro-1,4-dihydro-7-piperazin-1-yl-4-oxoquinoline-3-carboxylates.
    Sharma PC; Jain S
    Acta Pol Pharm; 2008; 65(5):551-6. PubMed ID: 19051601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. N-Hydroxy-1,2-disubstituted-1H-benzimidazol-5-yl acrylamides as novel histone deacetylase inhibitors: design, synthesis, SAR studies, and in vivo antitumor activity.
    Wang H; Yu N; Song H; Chen D; Zou Y; Deng W; Lye PL; Chang J; Ng M; Sun ET; Sangthongpitag K; Wang X; Wu X; Khng HH; Fang L; Goh SK; Ong WC; Bonday Z; Stünkel W; Poulsen A; Entzeroth M
    Bioorg Med Chem Lett; 2009 Mar; 19(5):1403-8. PubMed ID: 19181524
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 2-aroylindoles and 2-aroylbenzofurans with N-hydroxyacrylamide substructures as a novel series of rationally designed histone deacetylase inhibitors.
    Mahboobi S; Sellmer A; Höcher H; Garhammer C; Pongratz H; Maier T; Ciossek T; Beckers T
    J Med Chem; 2007 Sep; 50(18):4405-18. PubMed ID: 17691763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and antibacterial activity of egonol derivatives.
    Oztürk SE; Akgül Y; Anil H
    Bioorg Med Chem; 2008 Apr; 16(8):4431-7. PubMed ID: 18321718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Synthesis and antibacterial activity of thiosemicarbazones of 3-acylquinolones].
    Rádl S; Bartonová M; Kovárová L
    Cesk Farm; 1991 Nov; 40(4-5):145-7. PubMed ID: 1668232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. (S)-N-{3-[1-cyclopropyl-1-(2,4-difluoro-phenyl)-ethyl]-1H-indol-7-yl}-methanesulfonamide: a potent, nonsteroidal, functional antagonist of the mineralocorticoid receptor.
    Bell MG; Gernert DL; Grese TA; Belvo MD; Borromeo PS; Kelley SA; Kennedy JH; Kolis SP; Lander PA; Richey R; Sharp VS; Stephenson GA; Williams JD; Yu H; Zimmerman KM; Steinberg MI; Jadhav PK
    J Med Chem; 2007 Dec; 50(26):6443-5. PubMed ID: 18038968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kv7/KCNQ/M and HCN/h, but not KCa2/SK channels, contribute to the somatic medium after-hyperpolarization and excitability control in CA1 hippocampal pyramidal cells.
    Gu N; Vervaeke K; Hu H; Storm JF
    J Physiol; 2005 Aug; 566(Pt 3):689-715. PubMed ID: 15890705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ADX47273 [S-(4-fluoro-phenyl)-{3-[3-(4-fluoro-phenyl)-[1,2,4]-oxadiazol-5-yl]-piperidin-1-yl}-methanone]: a novel metabotropic glutamate receptor 5-selective positive allosteric modulator with preclinical antipsychotic-like and procognitive activities.
    Liu F; Grauer S; Kelley C; Navarra R; Graf R; Zhang G; Atkinson PJ; Popiolek M; Wantuch C; Khawaja X; Smith D; Olsen M; Kouranova E; Lai M; Pruthi F; Pulicicchio C; Day M; Gilbert A; Pausch MH; Brandon NJ; Beyer CE; Comery TA; Logue S; Rosenzweig-Lipson S; Marquis KL
    J Pharmacol Exp Ther; 2008 Dec; 327(3):827-39. PubMed ID: 18753411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serotonin1A autoreceptor activation by S 15535 enhances circadian activity rhythms in hamsters: evaluation of potential interactions with serotonin2A and serotonin2C receptors.
    Gannon RL; Millan MJ
    Neuroscience; 2006; 137(1):287-99. PubMed ID: 16289351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and antifungal activities of some aryl [3-(imidazol-1-yl/triazol-1-ylmethyl) benzofuran-2-yl] ketoximes.
    Gündoğdu-Karaburun N; Benkli K; Tunali Y; Uçucu U; Demirayak S
    Eur J Med Chem; 2006 May; 41(5):651-6. PubMed ID: 16554110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Zinc pyrithione-mediated activation of voltage-gated KCNQ potassium channels rescues epileptogenic mutants.
    Xiong Q; Sun H; Li M
    Nat Chem Biol; 2007 May; 3(5):287-96. PubMed ID: 17435769
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and biological activity of functionalized indole-2-carboxylates, triazino- and pyridazino-indoles.
    El-Gendy AA; Said MM; Ghareb N; Mostafa YM; El-Ashry el SH
    Arch Pharm (Weinheim); 2008 May; 341(5):294-300. PubMed ID: 18404776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological characterization of a new, orally active and potent allosteric metabotropic glutamate receptor 1 antagonist, 4-[1-(2-fluoropyridin-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-1(2H)-carboxamide (FTIDC).
    Suzuki G; Kimura T; Satow A; Kaneko N; Fukuda J; Hikichi H; Sakai N; Maehara S; Kawagoe-Takaki H; Hata M; Azuma T; Ito S; Kawamoto H; Ohta H
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1144-53. PubMed ID: 17360958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. BL-1249 [(5,6,7,8-tetrahydro-naphthalen-1-yl)-[2-(1H-tetrazol-5-yl)-phenyl]-amine]: a putative potassium channel opener with bladder-relaxant properties.
    Tertyshnikova S; Knox RJ; Plym MJ; Thalody G; Griffin C; Neelands T; Harden DG; Signor L; Weaver D; Myers RA; Lodge NJ
    J Pharmacol Exp Ther; 2005 Apr; 313(1):250-9. PubMed ID: 15608074
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biophysical characterization of the new human ether-a-go-go-related gene channel opener NS3623 [N-(4-bromo-2-(1H-tetrazol-5-yl)-phenyl)-N'-(3'-trifluoromethylphenyl)urea].
    Hansen RS; Diness TG; Christ T; Wettwer E; Ravens U; Olesen SP; Grunnet M
    Mol Pharmacol; 2006 Oct; 70(4):1319-29. PubMed ID: 16825484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hantzsch 1,4-dihydropyridines containing a diazen-1-ium-1,2-diolate nitric oxide donor moiety to study calcium channel antagonist structure-activity relationships and nitric oxide release.
    Nguyen JT; Velázquez CA; Knaus EE
    Bioorg Med Chem; 2005 Mar; 13(5):1725-38. PubMed ID: 15698790
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MF498 [N-{[4-(5,9-Diethoxy-6-oxo-6,8-dihydro-7H-pyrrolo[3,4-g]quinolin-7-yl)-3-methylbenzyl]sulfonyl}-2-(2-methoxyphenyl)acetamide], a selective E prostanoid receptor 4 antagonist, relieves joint inflammation and pain in rodent models of rheumatoid and osteoarthritis.
    Clark P; Rowland SE; Denis D; Mathieu MC; Stocco R; Poirier H; Burch J; Han Y; Audoly L; Therien AG; Xu D
    J Pharmacol Exp Ther; 2008 May; 325(2):425-34. PubMed ID: 18287210
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.